期刊文献+

系统性红斑狼疮患者血浆D-二聚体水平测定及其临床意义 被引量:11

The levels of plasma D-dimer and its clinical significance in patients with systemic lupus erythematosus
在线阅读 下载PDF
导出
摘要 目的了解系统性红斑狼疮(SLE)患者D-二聚体的水平及其临床价值。方法用单克隆抗体乳胶凝集试验法测定62例SLE患者血浆D-二聚体水平,研究其与SLE的疾病活动、临床表现的关系及治疗前后的变化。结果(1)SLE患者血浆D-二聚体水平较正常组显著增高(P<0.001);治疗后血浆D-二聚体水平较治疗前明显降低(P<0.05);(2)血浆D-二聚体水平与SLE DAI得分呈显著正相关(r=0.451,P<0.01);(3)血浆D-二聚体水平在初发患者中明显高于复发者(P<0.01),合并浆膜炎、白细胞降低及栓塞的患者分别显著高于无浆膜炎、白细胞正常及无栓塞的患者(均P<0.01);(4)抗心磷脂抗体阳性、抗dsDNA抗体阳性患者的血浆D-二聚体水平高于抗心磷脂抗体阴性、抗dsDNA抗体阴性者(分别为P<0.01,P<0.05);(5)SLE患者血浆D-二聚体水平与血沉呈正相关(r=0.428,P<0.001),与补体C3水平呈负相关(r=-0.275,P<0.05)。结论SLE患者血浆D-二聚体检测有助于SLE疾病活动性和临床疗效的评估。 Objective To study the clinical significance of plasma D-dimer in patients with systemic lu- pus erythematosus (SLE). Methods The levels of plasma D-dimer in 62 SLE patients were measured by monoclonal antibody latex agglutination test. Results The levels of D-dimer in SLE patients were significantly higher than those in the controls(P〈0.001 ), the levels of plasma D-dimer were significantly decreased (P〈0.05) in 10 patients and after the treatment. The levels were showed a significant positive correlation with SLEDAI scores(r=0.572,P〈0.001 ). The levels of plasma D-dimer in SLE patients who were the first time at- tacked with SLE were significantly higher than those in SLE patients with recrudescence (P〈0.01). The levels of plasma D-dimer in SLE patients with serositis, leucopenia, thrombosis were significantly higher than those without these clinical manifestations(P〈0.01 ). The levels of plasma D-dimer in SLE patients with anti-double- stranded DNA positive group were significantly higher than those in the negative group, meanwhile the levels of plasma D-dimer in SLE patients with anticardiolipid antibodies positive group were significantly higher than those in the negative group. There was a significantly positive correlation between levels of plasma D-dimer and ESR(r=0.428,P〈0.001 ),and a negative correlation between levels of plasma D-dimer and C3 levels(r=- 0.275 ,P〈0.05). Conclusion Levels of plasma D-dimer in SLE patients is valuable for assessment of disease activity and the rapeutic effect.
出处 《现代实用医学》 2007年第3期181-184,共4页 Modern Practical Medicine
关键词 系统性红斑狼疮 D-二聚体 血栓形成倾向 纤溶酶原激活物 自身抗体 Systemic lupus erythematosus D-dimer hypercoagulative and fibrinolytic
作者简介 郑小庆(1983-),女,浙江省衢州市人,医师。
  • 相关文献

参考文献15

  • 1Hasselaar P,DerKsen RHWM,Blokzij L,et al.Rsik factors for thrombosis in lupus patients[J].Ann Rheum Dis,1989,48:933.
  • 2Bombardier C,GladmanDD,UrowitzMB,et al.Committee on prognosis studies in SLE:derivation of the SLEDAL:a disease activity index for lupus patients[J].ArthritisRheum,1992,35:630.
  • 3Schorer AE.Discordant effects on eicosanoid and fibrin degradation Products in two murine models of antiphospholipid antibody[J].Thromb Res,1997,85(4):295-304.
  • 4AtsumiT,Kham ashta MA,AndujarC,et al.Elevated jplasma Lipoprotein (a) level an its association with impaired fibrinolysis in patients with antiphospholipid syndrome[J].JRhematol,1998,25(1):69-70.
  • 5窦春江,王晋平,居军,白兰乡.血浆同型半胱氨酸与系统性红斑狼疮关系的探讨[J].临床内科杂志,2005,22(4):265-267. 被引量:2
  • 6Ertenlil,Kiraz S,Elik,et al.Changes in the concentration and distribution of tissue factor path way inhibitor in Behcet.s disease and systemiclupus erythematosus:effect on the prethrombotic state[J].AnnRheumDis,2001,60:1149.
  • 7Inoh M,Tokuda M,Kiuchi H,et al.Evaluating systemic lupus erythematosus disease activity using molecula rmarkers of hemostasis[J].ArthritisRheum,1996,39(2):287-291.
  • 8杨旭燕,吴寿延.系统性红斑狼疮患者血浆D-二聚体水平测定及其临床意义[J].临床内科杂志,2000,17(3):159-160. 被引量:14
  • 9王杰,黄肖耆,殷文金,秦志芳.SLE患者ACA与D-二聚体的检测及意义[J].江苏医药,1997,23(6):417-418. 被引量:2
  • 10Luis Gómez-Pacheco MD,Antonio R,Villa MD,et al.Serum anti-β2-glycoprotein-Ⅰ and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients[J].The American journal of medicine,1999,106 (4):417-423.

二级参考文献23

  • 1姜学义,峰下哲,韩春雷,杨学莉,汪整辉,寇丽筠,王黎曼,杨杰.系统性红斑狼疮患者纤溶功能测定[J].中华皮肤科杂志,1995,28(4):207-209. 被引量:5
  • 2陈飞 张金黎 李明 等.D-二聚体在肾脏疾病中的临床研究[J].中华肾脏病杂志,1998,14(1):14-14.
  • 3Manzi S,Meilahn EN,Rairie JE,et al.Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus:comparison with the Framingham study.Am J Epidemiol,1997,145:408-415.
  • 4Refsun H,Ueland PM.Clinical significance of pharmacological modulation of homocysteine metabolism.TIPS,1990,11:411-416.
  • 5Petri M,Roubenoff R,Dallal GE,et al.Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus.The Lancet.1996,348:1120-1124.
  • 6Ubbink JB,Vermaak WJH,Van der Merwa A,et al.Vitamin require ments for the treatment of hyperhomocysteinemia in humans.J Nutr,1994,124:1297-1933.
  • 7Hofmann MA,Lalla E,Lu Y,et al.Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model.J Clin Invest,2001,107:675-683.
  • 8Stamler JS,Osborne JA,Jaraki O,et al.Adverse vascular effects of homocysteine are modulated by endothelium derived relaxing factor and related oxides of nitrogen.J Clin Invest,1993,91:308-318.
  • 9Ward MM.Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus.Arthritis Rheum,1999,42:338-346.
  • 10Inoh M,Tokuda M,Kiuchi H,et al.Evaluating systemic lupus erythematosus diseaseactivity using molecular markers of hemostasis.Arthritis Rheum,1996 Feb,39(2)∶287-291.

共引文献21

同被引文献105

引证文献11

二级引证文献150

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部